- Home
- ALLR vs DRCT Comparison
ALLR vs DRCT Comparison
Compare ALLR & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- DRCT
- Stock Information
- Founded
- ALLR 2004
- DRCT 2018
- Country
- ALLR United States
- DRCT United States
- Employees
- ALLR N/A
- DRCT N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- DRCT Computer Software: Programming Data Processing
- Sector
- ALLR Health Care
- DRCT Technology
- Exchange
- ALLR Nasdaq
- DRCT Nasdaq
- Market Cap
- ALLR 15.8M
- DRCT 16.7M
- IPO Year
- ALLR N/A
- DRCT 2022
- Fundamental
- Price
- ALLR $1.01
- DRCT $0.59
- Analyst Decision
- ALLR
- DRCT Strong Buy
- Analyst Count
- ALLR 0
- DRCT 1
- Target Price
- ALLR N/A
- DRCT $6.00
- AVG Volume (30 Days)
- ALLR 417.1K
- DRCT 151.3K
- Earning Date
- ALLR 08-04-2025
- DRCT 05-06-2025
- Dividend Yield
- ALLR N/A
- DRCT N/A
- EPS Growth
- ALLR N/A
- DRCT N/A
- EPS
- ALLR N/A
- DRCT N/A
- Revenue
- ALLR N/A
- DRCT $48,170,000.00
- Revenue This Year
- ALLR N/A
- DRCT $50.71
- Revenue Next Year
- ALLR N/A
- DRCT $26.31
- P/E Ratio
- ALLR N/A
- DRCT N/A
- Revenue Growth
- ALLR N/A
- DRCT N/A
- 52 Week Low
- ALLR $0.61
- DRCT $0.44
- 52 Week High
- ALLR $7.45
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- ALLR 53.22
- DRCT 55.55
- Support Level
- ALLR $0.95
- DRCT $0.56
- Resistance Level
- ALLR $1.08
- DRCT $0.68
- Average True Range (ATR)
- ALLR 0.07
- DRCT 0.04
- MACD
- ALLR 0.01
- DRCT 0.01
- Stochastic Oscillator
- ALLR 59.39
- DRCT 49.94
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.